Cargando…
Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics
The treatment of chronic pain is poorly managed by current analgesics, and there is a need for new classes of drugs. We recently developed a series of bioactive lipids that inhibit the human glycine transporter GlyT2 (SLC6A5) and provide analgesia in animal models of pain. Here, we have used functio...
Autores principales: | Mostyn, Shannon N, Wilson, Katie A, Schumann-Gillett, Alexandra, Frangos, Zachary J, Shimmon, Susan, Rawling, Tristan, Ryan, Renae M, O'Mara, Megan L, Vandenberg, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797481/ https://www.ncbi.nlm.nih.gov/pubmed/31621581 http://dx.doi.org/10.7554/eLife.47150 |
Ejemplares similares
-
The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity
por: Wilson, Katie A., et al.
Publicado: (2021) -
Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2
por: Frangos, Zachary J, et al.
Publicado: (2023) -
Identification of a 3(rd) Na(+) Binding Site of the Glycine Transporter, GlyT2
por: Subramanian, Nandhitha, et al.
Publicado: (2016) -
Correction: Identification of a 3(rd) Na(+) Binding Site of the Glycine Transporter, GlyT2
por: Subramanian, Nandhitha, et al.
Publicado: (2016) -
Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies
por: Zafra, Francisco, et al.
Publicado: (2016)